Galina Schevzov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Galina Schevzov has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
Peter Gunning
8 shared publicationsPeter W. Gunning
Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia
8 shared publications- Peter W. Gunning
Oncology Research Unit, The Children's Hospital at Westmead, and Muscle Development Unit, Children's Medical Research Institute, Westmead; New South Wales, Australia
7 shared publications Bernadette Vrhovski
6 shared publicationsJim J.-C. Lin
5 shared publications- Nicole S. Bryce
School of Medical Sciences, University of New South Wales, Sydney, Australia
5 shared publications
Latest Publications
- 1 January 2012
- Published by Elsevier
- Vol. 298, 33-94
Functional Diversity of Actin Cytoskeleton in Neurons and its Regulation by Tropomyosin
- 1 January 2012
- Published by Elsevier
- Vol. 298, 33-94
Functional Diversity of Actin Cytoskeleton in Neurons and its Regulation by Tropomyosin
- 1 June 2011
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 300 (6) , C1356-C1365
Tropomyosin variants describe distinct functional subcellular domains in differentiated vascular smooth muscle cells
Tropomyosin (Tm) is known to be an important gatekeeper of actin function. Tm isoforms are encoded by four genes, and each gene produces several variants by alternative splicing, which have been proposed to play roles in motility, proliferation, and apoptosis. Smooth muscle studies have focused on gizzard smooth muscle, where a heterodimer of Tm from the α-gene (Tmsm-α) and from the β-gene (Tmsm-β) is associated with contractile filaments. In this study we examined Tm in differentiated mammalian vascular smooth muscle (dVSM). Liquid chromatography-tandem mass spectrometry (LC MS/MS) analysis and Western blot screening with variant-specific antibodies revealed that at least five different Tm proteins are expressed in this tissue: Tm6 (Tmsm-α) and Tm2 from the α-gene, Tm1 (Tmsm-β) from the β-gene, Tm5NM1 from the γ-gene, and Tm4 from the δ-gene. Tm6 is by far most abundant in dVSM followed by Tm1, Tm2, Tm5NM1, and Tm4. Coimmunoprecipitation and coimmunofluorescence studies demonstrate that Tm1 and Tm6 coassociate with different actin isoforms and display different intracellular localizations. Using an antibody specific for cytoplasmic γ-actin, we report here the presence of a γ-actin cortical cytoskeleton in dVSM cells. Tm1 colocalizes with cortical cytoplasmic γ-actin and coprecipitates with γ-actin. Tm6, on the other hand, is located on contractile bundles. These data indicate that Tm1 and Tm6 do not form a classical heterodimer in dVSM but rather describe different functional cellular compartments.
- 1 June 2011
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 300 (6) , C1356-C1365
Tropomyosin variants describe distinct functional subcellular domains in differentiated vascular smooth muscle cells
Tropomyosin (Tm) is known to be an important gatekeeper of actin function. Tm isoforms are encoded by four genes, and each gene produces several variants by alternative splicing, which have been proposed to play roles in motility, proliferation, and apoptosis. Smooth muscle studies have focused on gizzard smooth muscle, where a heterodimer of Tm from the α-gene (Tmsm-α) and from the β-gene (Tmsm-β) is associated with contractile filaments. In this study we examined Tm in differentiated mammalian vascular smooth muscle (dVSM). Liquid chromatography-tandem mass spectrometry (LC MS/MS) analysis and Western blot screening with variant-specific antibodies revealed that at least five different Tm proteins are expressed in this tissue: Tm6 (Tmsm-α) and Tm2 from the α-gene, Tm1 (Tmsm-β) from the β-gene, Tm5NM1 from the γ-gene, and Tm4 from the δ-gene. Tm6 is by far most abundant in dVSM followed by Tm1, Tm2, Tm5NM1, and Tm4. Coimmunoprecipitation and coimmunofluorescence studies demonstrate that Tm1 and Tm6 coassociate with different actin isoforms and display different intracellular localizations. Using an antibody specific for cytoplasmic γ-actin, we report here the presence of a γ-actin cortical cytoskeleton in dVSM cells. Tm1 colocalizes with cortical cytoplasmic γ-actin and coprecipitates with γ-actin. Tm6, on the other hand, is located on contractile bundles. These data indicate that Tm1 and Tm6 do not form a classical heterodimer in dVSM but rather describe different functional cellular compartments.
- 1 April 2011
- Published by Elsevier in Current Biology
- Vol. 21 (7) , 539-550
A Molecular Pathway for Myosin II Recruitment to Stress Fibers
- 1 April 2011
- Published by Elsevier in Current Biology
- Vol. 21 (7) , 539-550
A Molecular Pathway for Myosin II Recruitment to Stress Fibers
- 1 November 2010
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 8 (7) , 107
334 Tropomyosin Tm5NM1: A novel target for cancer therapy
- 1 November 2010
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 8 (7) , 107
334 Tropomyosin Tm5NM1: A novel target for cancer therapy
- 1 July 2010
- Published by Elsevier in European Journal of Cell Biology
- Vol. 89 (7) , 489-498
New aspects of tropomyosin-regulated neuritogenesis revealed by the deletion of Tm5NM1 and 2
- 1 July 2010
- Published by Elsevier in European Journal of Cell Biology
- Vol. 89 (7) , 489-498
New aspects of tropomyosin-regulated neuritogenesis revealed by the deletion of Tm5NM1 and 2
- 1 May 2010
- Published by Elsevier in Journal of Structural Biology
- Vol. 170 (2) , 286-293
Alternatively spliced N-terminal exons in tropomyosin isoforms do not act as autonomous targeting signals
- 1 May 2010
- Published by Elsevier in Journal of Structural Biology
- Vol. 170 (2) , 286-293
Alternatively spliced N-terminal exons in tropomyosin isoforms do not act as autonomous targeting signals
- Open Access
- 1 April 2010
- Published by Taylor & Francis in Cell Adhesion & Migration
- Vol. 4 (2) , 226-234
Tropomyosin isoform modulation of focal adhesion structure and cell migration
Orderly cell migration is essential for embryonic development, efficient wound healing and a functioning immune system and the dysregulation of this process leads to a number of pathologies. The sp...
- 1 April 2010
- Published by Taylor & Francis in Cell Adhesion & Migration
- Vol. 4 (2) , 226-234
Open AccessTropomyosin isoform modulation of focal adhesion structure and cell migration
Orderly cell migration is essential for embryonic development, efficient wound healing and a functioning immune system and the dysregulation of this process leads to a number of pathologies. The sp...
- 1 March 2009
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 29 (6) , 1506-1514
Tropomyosin Isoform Expression Regulates the Transition of Adhesions To Determine Cell Speed and Direction
The balance of transition between distinct adhesion types contributes to the regulation of mesenchymal cell migration, and the characteristic association of adhesions with actin filaments led us to question the role of actin filament-associating proteins in the transition between adhesive states. Tropomyosin isoform association with actin filaments imparts distinct filament structures, and we have thus investigated the role for tropomyosins in determining the formation of distinct adhesion structures. Using combinations of overexpression, knockdown, and knockout approaches, we establish that Tm5NM1 preferentially stabilizes focal adhesions and drives the transition to fibrillar adhesions via stabilization of actin filaments. Moreover, our data suggest that the expression of Tm5NM1 is a critical determinant of paxillin phosphorylation, a signaling event that is necessary for focal adhesion disassembly. Thus, we propose that Tm5NM1 can regulate the feedback loop between focal adhesion disassembly and focal complex formation at the leading edge that is required for productive and directed cell movement.
- 1 March 2009
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 29 (6) , 1506-1514
Tropomyosin Isoform Expression Regulates the Transition of Adhesions To Determine Cell Speed and Direction
The balance of transition between distinct adhesion types contributes to the regulation of mesenchymal cell migration, and the characteristic association of adhesions with actin filaments led us to question the role of actin filament-associating proteins in the transition between adhesive states. Tropomyosin isoform association with actin filaments imparts distinct filament structures, and we have thus investigated the role for tropomyosins in determining the formation of distinct adhesion structures. Using combinations of overexpression, knockdown, and knockout approaches, we establish that Tm5NM1 preferentially stabilizes focal adhesions and drives the transition to fibrillar adhesions via stabilization of actin filaments. Moreover, our data suggest that the expression of Tm5NM1 is a critical determinant of paxillin phosphorylation, a signaling event that is necessary for focal adhesion disassembly. Thus, we propose that Tm5NM1 can regulate the feedback loop between focal adhesion disassembly and focal complex formation at the leading edge that is required for productive and directed cell movement.
- Open Access
- 5 February 2009
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 27 (5) , 1098-1108
Methylguanine DNA Methyltransferase-Mediated Drug Resistance-Based Selective Enrichment and Engraftment of Transplanted Stem Cells in Skeletal Muscle
Cell replacement therapy using stem cell transplantation holds much promise in the field of regenerative medicine. In the area of hematopoietic stem cell transplantation, O6-methylguanine-DNA methyltransferase MGMT (P140K) gene-mediated drug resistance-based in vivo enrichment strategy of donor stem cells has been shown to achieve up to 75%–100% donor cell engraftment in the host's hematopoietic stem cell compartment following repeated rounds of selection. This strategy, however, has not been applied in any other organ system. We tested the feasibility of using this MGMT (P140K)-mediated enrichment strategy for cell transplantation in skeletal muscles of mice. We demonstrate that muscle cells expressing an MGMT (P140K) drug resistance gene can be protected and selectively enriched in response to alkylating chemotherapy both in vitro and in vivo. Upon transplantation of MGMT (P140K)-expressing male CD34+ve donor stem cells isolated from regenerating skeletal muscle into injured female muscle treated with alkylating chemotherapy, donor cells showed enhanced engraftment in the recipient muscle 7 days following transplantation as examined by quantitative-polymerase chain reaction using Y-chromosome specific primers. Fluorescent in situ hybridization analysis using a Y-chromosome paint probe revealed donor-derived de novo muscle fiber formation in the recipient muscle 14 days following transplantation, with approximately 12.5% of total nuclei within the regenerated recipient muscle being of donor origin. Following engraftment, the chemo-protected donor CD34+ve cells induced substantial endogenous regeneration of the chemo-ablated host muscle that is otherwise unable to self-regenerate. We conclude that the MGMT (P140K)-mediated enrichment strategy can be successfully implemented in muscle. Stem Cells 2009;27:1098–1108
- 5 February 2009
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 27 (5) , 1098-1108
Open AccessMethylguanine DNA Methyltransferase-Mediated Drug Resistance-Based Selective Enrichment and Engraftment of Transplanted Stem Cells in Skeletal Muscle
Cell replacement therapy using stem cell transplantation holds much promise in the field of regenerative medicine. In the area of hematopoietic stem cell transplantation, O6-methylguanine-DNA methyltransferase MGMT (P140K) gene-mediated drug resistance-based in vivo enrichment strategy of donor stem cells has been shown to achieve up to 75%–100% donor cell engraftment in the host's hematopoietic stem cell compartment following repeated rounds of selection. This strategy, however, has not been applied in any other organ system. We tested the feasibility of using this MGMT (P140K)-mediated enrichment strategy for cell transplantation in skeletal muscles of mice. We demonstrate that muscle cells expressing an MGMT (P140K) drug resistance gene can be protected and selectively enriched in response to alkylating chemotherapy both in vitro and in vivo. Upon transplantation of MGMT (P140K)-expressing male CD34+ve donor stem cells isolated from regenerating skeletal muscle into injured female muscle treated with alkylating chemotherapy, donor cells showed enhanced engraftment in the recipient muscle 7 days following transplantation as examined by quantitative-polymerase chain reaction using Y-chromosome specific primers. Fluorescent in situ hybridization analysis using a Y-chromosome paint probe revealed donor-derived de novo muscle fiber formation in the recipient muscle 14 days following transplantation, with approximately 12.5% of total nuclei within the regenerated recipient muscle being of donor origin. Following engraftment, the chemo-protected donor CD34+ve cells induced substantial endogenous regeneration of the chemo-ablated host muscle that is otherwise unable to self-regenerate. We conclude that the MGMT (P140K)-mediated enrichment strategy can be successfully implemented in muscle. Stem Cells 2009;27:1098–1108
- Open Access
- 1 January 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (1) , 275-283
Divergent Regulation of the Sarcomere and the Cytoskeleton
- 1 January 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (1) , 275-283
Open AccessDivergent Regulation of the Sarcomere and the Cytoskeleton